Acute Coronary Syndrome
Marijuana use associated with increased risk of mortality among acute MI patients
March 3, 2008 | Michael O'Riordan

Boston, MA - For acute MI patients wondering if the next heart attack is the big one, maybe smoking marijuana relieves some of that stress and anxiety, but it isn't helping their chances of living any longer. New preliminary research suggests that marijuana use in acute MI survivors is associated with a threefold higher risk of mortality after infarction [1].

"For all the thousands and thousands of studies we've done on people who have had heart attacks, virtually nobody asks them about their marijuana use," said lead investigator Dr Kenneth Mukamal (Beth Israel Deaconess Medical Center, Boston, MA). "There is an extraordinary lack of data for exposure to something as common as marijuana. Every single study asks people if they smoke, if they drink alcohol, but we never ask about marijuana."

Speaking to heartwire about the study, which is published in the March 2008 issue of the American Heart Journal, Mukamal said that previous research has shown marijuana to have cardiovascular effects that might pose a risk, particularly to older adults and those with coronary disease, such as an increase in resting heart rate. Other studies have shown transient increases in MI risk, possibly due to carbon-monoxide exposure and an increase in heart rate, said Mukamal.

Oral cannabinoid therapy, however, has also been shown to stop atherosclerosis in a mouse model and to play other immunologic roles. With these differing effects of marijuana in mind, the group set out to study the relation between marijuana use and coronary heart disease in 1913 adults hospitalized with MI between 1989 and 1994. Of these, 52 patients reported marijuana use during the previous year, and 317 died during a mean follow-up of 3.8 years.

In an adjusted analysis, marijuana use was associated with a three times greater risk of all-cause, cardiovascular, and noncardiovascular death following acute MI, and there was a greater risk among those who smoked more frequently.

Hazard ratios for all-cause, cardiovascular, and noncardiovascular mortality after acute MI according to marijuana use

Patients who smoked marijuana within the previous year
Hazard ratio
(95% CI)
All
3.0 (1.3-7.0)
Patients who smoked marijuana less than weekly
2.5 (0.9-7.3)
Patients who smoked marijuana weekly or more
4.2 (1.2-14.3)

To download table as a slide, click on slide logo below

The investigators note that the study was small and they did not have a sufficient number of cases to evaluate cardiovascular and noncardiovascular deaths with accuracy. However, Mukamal told heartwire that they observed a particularly greater risk of noncardiovascular mortality associated with use among acute MI patients, which makes sense if patients are smoking to ease pain and discomfort from AIDS or other terminal illnesses.

The risk, however, was also doubled for cardiovascular mortality and, although not significantly, for cardiovascular disease. "We shouldn't see the increase in cardiovascular mortality if people are smoking marijuana only because they are dying of other things," he said. "This provides a hint that there is a true cardiovascular effect of marijuana here."

Mukamal, however, cautioned that the findings are exploratory and that further research is needed to identify the risks with precision.

Source
  1. Mukamal KJ, Maclure M, Muller JE, Mittleman MA. An exploratory prospective study of marijuana use and mortality following acute myocardial infarction. Am Heart J 2008; 155:465-470.



Your comments
Marijuana use associated with increased risk of mortality among acute MI patients
# 1 of 4
March 05, 2008 09:51 PM (EST)
Melissa Walton-Shirley
Right on man!
A little bird who shall remain nameless made a little quip regarding this topic:
Following MI, You must not keep getting High, or else you will die!
midnight tokers beware! or better yet, WE should be aware that some of our patients may be moderate to heavy utilizers of marijuana.
the salient point of this story is that we don't querry marijuana use in the context of a risk factor. We also don't think of the traditional 55 year old patient as a pot smoker but we should remember that 1967 was 30 years ago!
I'm reminded that at least on two occasions, a female in her late sixties to early seventies told me of their addiction to cocaine. I was embarassed that one of those patients volunteered that information without my having asked.
So man........take like a history or something everytime someone comes in with like uh.....chest pain because well.......uh......it could be important or something....OK man?

Melissa
# 2 of 4
March 05, 2008 09:57 PM (EST)
Melissa Walton-Shirley
And no, I don't smoke pot. Just can't do math
I've never even done a Bill Clinton on that issue. remember, smoked but didn't inhale? (sorry, I love Bill, it's a weakness, but for all of you republicans, I voted for Ronald R. too)
I just can't do math. 1967 was 40 years ago.
sorry
Melissa
# 3 of 4
March 06, 2008 05:49 AM (EST)
john lanid
sparkin a phatty!
Is smokin bones really one of the biggest problems we face..I mean really aren't there bigger issues?
# 4 of 4
March 06, 2008 07:39 PM (EST)
Melissa Walton-Shirley
Sparin a Phatty?
Well John,
It depends on whether you're the one smokin' those bones and whether or not your troponin is coming down from 20. Also, I think the salient point is that we can't ever be certain of our patients' habits unless we ask them and then sometimes, we can't even when we do.
Like the often say, the "chances of something happening maybe small, but if they happen to you, it was 100%.
Sparkin a phatty? Never heard that one!
I'm certain there is a peace frog somewhere in this conversation.
Melissa

You have to be logged in to add a comment to this article
Login
Username 
Password 
  Forgot your password?
 
Remember me on this computer
 
Register
Click on "register" to create a account - It is free....
 
button
Previews
Featured CME
Inside: Acute Coronary Syndrome
Acute Coronary Syndrome
1 COMMENT - Jun 19, 2008 09:37 EDT
In light of recent data, how do you balance the risk and benefit of current treatment options? Answer 3 short polling questions in the Antiplatelet Therapies section and see what your colleagues do.
Acute Coronary Syndrome
May 27, 2008 11:33 EDT
Optimal management of individual patients requires the clinician to have a clear understanding of both the mechanisms and challenges of treatment. Drs Badimon, Kristensen, Spaulding and Storey's presentations reflect that while current guidelines recommend that patients presenting with acute coronary syndromes or patients undergoing percutaneous coronary intervention should be treated with dual-antiplatelet therapy, that is, they should receive aspirin and a thienopyridine, often patients are undertreated in both in hospital and on discharge.
Acute Coronary Syndrome
Jun 27, 2008 12:22 EDT
Distinguished faculty members of The Year 2008 EDICT (Emergency Department and Interventional Cardiology Therapeutic teams) for ACS initiative are pleased to invite you to participate in a regional, science-to-strategy summit focused on upstream and downstream management of patients with STEMI and UA/NSTEMI.
Acute Coronary Syndrome
May 21, 2008 09:26 EDT
This program will address new dimensions and practice advances with scientific rigor and expert analysis, including case studies.
Acute Coronary Syndrome
Jun 23, 2008 11:00 EDT
Current guidelines for thienopyridines in PCI note the lack of RCT data for higher loading doses. Read Dr Wang's lowdown on loading doses, including recent presentations from the 2008 SCAI-ACCi2 meeting. Then watch Drs Mehta and Mehran discuss where CURRENT-OASIS-7 will fit in.
Acute Coronary Syndrome
2 COMMENTS - Jun 3, 2008 14:22 EDT
Balancing antithrombotic efficacy with risk of bleeding: Join our international panel of experts, Steen Husted, José Carlos Nicolau, Sunil Rao and Robert Storey as they review the mechanisms of platelet activation and emerging evidence from ongoing studies to novel antiplatelet therapies.